Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
59.74
+0.02 (0.03%)
Real-time:   12:29PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 58.81 - 59.89
52 week 33.62 - 59.89
Open 59.66
Vol / Avg. 95,039.00/169,881.00
Mkt cap 1.36B
P/E 79.24
Div/yield 0.10/0.67
EPS 0.75
Shares 22.54M
Beta 0.97
Inst. own 103%
Jan 28, 2015
Q3 2015 Abaxis Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 3, 2014
Abaxis Inc at Piper Jaffray Healthcare Conference
Nov 20, 2014
Abaxis Inc at Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 18, 2014
Abaxis Inc at Stifel Healthcare Conference
Nov 11, 2014
Abaxis Inc at Stephens Fall Investment Conference
Oct 22, 2014
Abaxis Inc Annual Shareholders Meeting
Oct 21, 2014
Q2 2015 Abaxis Inc Earnings Call
Oct 21, 2014
Q2 2015 Abaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 10.01% 8.25%
Operating margin 16.55% 12.10%
EBITD margin - 16.42%
Return on average assets 9.37% 6.77%
Return on average equity 10.85% 7.67%
Employees 520 -
CDP Score - -

Address

3240 Whipple Road
UNION CITY, CA 94587
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company�s segments include the medical market and the veterinary market. The Company has developed a blood analysis system incorporating all of these criteria into a 5.1 kilogram (11.2 pounds) portable analyzer and a series of menu-specific, multi-test single-use reagent discs. Abaxis markets its blood chemistry analyzers in the medical market and in the veterinary market. The Company markets the blood analysis system in the medical market under the name Piccolo Xpress. It markets the blood analysis system in the veterinary market under the name VetScan VS2.

Officers and directors

Clinton H. Severson Chairman of the Board, President, Chief Executive Officer
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Donald Peter Wood Chief Operations Officer
Age: 62
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 61
Bio & Compensation  - Reuters
Ross Taylor Vice President - Business Development & Investor Relations
Bio & Compensation  - Reuters
Craig M. Tockman Vice President, Sales & Marketing � NAAH
Age: 54
Bio & Compensation  - Reuters
Achim Henkel Vice President - Marketing for Pacific Rim, Vice President - Government Affairs, Managing Director of Abaxis Europe GmbH
Age: 56
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 68
Bio & Compensation  - Reuters